These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10616484)

  • 1. Efficacy and safety of losartan in renal transplant recipients.
    Hadjigavriel M; Kyriakides G
    Transplant Proc; 1999 Dec; 31(8):3300-1. PubMed ID: 10616484
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
    Kim W; Lee S; Kang SK; Yu HC; Cho BH; Park SK
    Transplant Proc; 2002 Dec; 34(8):3223-4. PubMed ID: 12493427
    [No Abstract]   [Full Text] [Related]  

  • 3. Losartan and renal transplantation.
    Aurup P; Smith RD
    Lancet; 1998 Mar; 351(9107):990. PubMed ID: 9734972
    [No Abstract]   [Full Text] [Related]  

  • 4. Losartan and renal transplantation.
    Horn S; Holzer H; Horina J
    Lancet; 1998 Jan; 351(9096):111. PubMed ID: 9439500
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term anti-proteinuric effect of Losartan in renal transplant recipients treated for hypertension.
    Calviño J; Lens XM; Romero R; Sánchez-Guisande D
    Nephrol Dial Transplant; 2000 Jan; 15(1):82-6. PubMed ID: 10607772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is losartan as effective as enalapril on posttransplant persistent proteinuria?
    Altiparmak MR; Trablus S; Apaydin S; Başar O; Sariyar M; Serdengeçti K; Erek E
    Transplant Proc; 2001; 33(7-8):3368-9. PubMed ID: 11750440
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation.
    Holgado R; Anaya F; Del Castillo D
    Nephrol Dial Transplant; 2001; 16 Suppl 1():117-20. PubMed ID: 11369838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of left ventricular hypertrophy by AT1 receptor blockade in renal transplant recipients.
    Klingbeil AU; Müller HJ; Delles C; Fleischmann E; Schmieder RE
    Am J Hypertens; 2000 Dec; 13(12):1295-300. PubMed ID: 11130774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
    Parati G; Giglio A; Lonati L; Destro M; Ricci AR; Cagnoni F; Pini C; Venco A; Maresca AM; Monza M; Grandi AM; Omboni S
    Clin Ther; 2010 Jul; 32(7):1270-84. PubMed ID: 20678675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Israeli experiences of treatment of hypertension with losartan (Ocsaar)--summary of the treatment of 421 patients in community health centers].
    Zimlichman R
    Harefuah; 1999 Dec; 137(12):597-603, 680. PubMed ID: 10959382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
    Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of moderate or severe arterial hypertension with losartan.
    Dimitrova A; Todorova M; Bianov K; Halachev N; Dineva S; Elenkova A
    Folia Med (Plovdiv); 1998; 40(3B Suppl 3):43-5. PubMed ID: 10205992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan/hydrochlorothiazide combination is safe and effective for morning hypertension in Very-Elderly patients.
    Uchiwa H; Kai H; Iwamoto Y; Anegawa T; Kajimoto H; Fukuda K; Imaizumi T; Fukumoto Y;
    Clin Exp Hypertens; 2018; 40(3):267-273. PubMed ID: 29083936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
    Sakallı H; Baskın E; Bayrakcı US; Moray G; Haberal M
    Exp Clin Transplant; 2014 Aug; 12(4):310-3. PubMed ID: 24447308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y; Liu G; Jiang B; Gao R; Chen L; Su L; Li J
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and effect on plasma B-type natriuretic peptide concentration of losartan-hydrochlorothiazide for hypertension uncontrolled by losartan-based therapy: subanalysis of a Multicentre Prospective Observational Study.
    Meno H; Inou T; Tanaka M; Tsuchiya Y; Shiga Y; Kobayashi K; Nakamura Y; Ota T; Kubara I
    Arzneimittelforschung; 2012 Sep; 62(9):414-9. PubMed ID: 22773432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.
    Oparil S; Aurup P; Snavely D; Goldberg A
    Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of angiotensin II AT 1 receptor reduces hematocrit in patients with posttransplant erythrocytosis.
    Tsang WK; Tong KL; Chan HW
    Transplant Proc; 1998 Nov; 30(7):3072-3. PubMed ID: 9838354
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression.
    Martínez-Castelao A; Hueso M; Sanz V; Rejas J; Sarrias J; Alsina J; Grinyó JM
    Transplant Proc; 2002 Feb; 34(1):403-6. PubMed ID: 11959345
    [No Abstract]   [Full Text] [Related]  

  • 20. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.